Villani, Melanie
Earnest, Arul
Smith, Karen
de Courten, Barbora
Zoungas, Sophia
Article History
Received: 10 October 2017
Accepted: 13 March 2018
First Online: 23 March 2018
Competing Interests
: S. Zoungas reports past participation in advisory boards and/or receiving honoraria from Amgen Australia Pty Ltd, AstraZeneca Pty Ltd/Bristol-Myers Squibb Australia Pty Ltd, Janssen-Cilag Pty Ltd, Merck Sharp & Dohme (Australia) Pty Ltd, Novartis Australia Pty Ltd, Sanofi Pty Ltd, Servier Laboratories Pty Ltd and Takeda Australia Pty Ltd for work unrelated to this paper as well as Monash University undertaking contract work for AstraZeneca Pty Ltd/Bristol-Myers Squibb Australia Pty Ltd.